Myxoma chest x ray: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 37: Line 37:
*Tumor mobility and distensibility.
*Tumor mobility and distensibility.
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Limited views of the mediastinum and cannot be used to evaluate extracardiac manifestations of disease.<ref name="pmid1943240">{{cite journal |vauthors=Reeder GS, Khandheria BK, Seward JB, Tajik AJ |title=Transesophageal echocardiography and cardiac masses |journal=Mayo Clin. Proc. |volume=66 |issue=11 |pages=1101–9 |year=1991 |pmid=1943240 |doi= |url=}}</ref>
*Limited views of the [[mediastinum]] and cannot be used to evaluate extracardiac manifestations of disease.<ref name="pmid1943240">{{cite journal |vauthors=Reeder GS, Khandheria BK, Seward JB, Tajik AJ |title=Transesophageal echocardiography and cardiac masses |journal=Mayo Clin. Proc. |volume=66 |issue=11 |pages=1101–9 |year=1991 |pmid=1943240 |doi= |url=}}</ref>
*TEE is an invasive imaging technique.
*[[Transesophageal echocardiography (TEE)|TEE]] is an invasive imaging technique.
*TT is limited by the imaging window, which can vary with the patient and operator experience.
*[[TTE]] is limited by the imaging window, which can vary with the patient and operator experience.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align=center|'''MRI'''
| style="padding: 5px 5px; background: #DCDCDC;" align=center|'''MRI'''
Line 52: Line 52:
* Provides some functional information such as, flow direction and flow velocity in large vessels.
* Provides some functional information such as, flow direction and flow velocity in large vessels.
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Cannot show calcification.
*Cannot show [[calcification]].
*High susceptibility to motion artifact.
*High susceptibility to motion [[artifact]].
*Dependent on regular electrocardiographic rhythms and cardiac gating.
*Dependent on regular electrocardiographic rhythms and cardiac gating.
|-
|-
Line 62: Line 62:
*Intracardiac heterogeneously low attenuating mass.
*Intracardiac heterogeneously low attenuating mass.
*The attenuation is usually lower than that of myocardium.
*The attenuation is usually lower than that of myocardium.
*Calcification is common
*[[Calcification]] is common
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*CT provides better soft-tissue contrast.
*CT provides better soft-tissue contrast.
Line 73: Line 73:
*Coronary angiography may be helpful to detect vascular supply of the tumor by the coronary arteries.
*Coronary angiography may be helpful to detect vascular supply of the tumor by the coronary arteries.
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*The angiographic findings of cardiac myxoma demonstrate feeding vessels, contrast medium poolings, and clusters of tortuous vessels that correspond to tumor vasculature
*The angiographic findings of cardiac myxoma demonstrate feeding vessels, contrast medium poolings, and clusters of [[tortuous]] vessels that correspond to tumor vasculature
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
*Angiography can detect the concomitant coronary disease and the unique vascular appearances of cardiac myxoma.
*Angiography can detect the concomitant coronary disease and the unique vascular appearances of cardiac myxoma.

Revision as of 15:16, 29 October 2019

Myxoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myxoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myxoma chest x ray On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myxoma chest x ray

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myxoma chest x ray

CDC on Myxoma chest x ray

Myxoma chest x ray in the news

Blogs on Myxoma chest x ray

Directions to Hospitals Treating Myxoma

Risk calculators and risk factors for Myxoma chest x ray

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Maria Fernanda Villarreal, M.D. [2] Cafer Zorkun, M.D., Ph.D. [3] Ahmad Al Maradni, M.D. [4]

Overview

There are no specific chest x-ray findings associated with cardiac myxoma, the results can be reported as normal.

Key Chest X-Ray Findings in Cardiac Myxoma

There are no specific chest x-ray findings associated with cardiac myxoma, the results can be reported as normal.[1] Related imaging findings include cardiomegaly, left atrial enlargement, vascular redistribution, prominent pulmonary trunk, and intracardiac tumoral calcification (rare).

Gallery


Imaging Technique Features Description Advantages Limitations
Two- or three-dimensional echocardiography
  • Echocardiography is usually the initial modality used for identification and evaluation of cardiac myxomas.
  • Hyperechogenic lesions with a well-defined stalk.
  • Protrusion into the ventricles is a common finding.
  • Real-time imaging
  • Tumor mobility and distensibility.
  • Limited views of the mediastinum and cannot be used to evaluate extracardiac manifestations of disease.[2]
  • TEE is an invasive imaging technique.
  • TTE is limited by the imaging window, which can vary with the patient and operator experience.
MRI
  • Evaluation of cardiac masses and is of greatest value when echocardiographic findings are suboptimal or when the lesion has an atypical location or appearance.
  • Cardiac myxomas appear spherical or ovoid with lobular contours, irregular in shape.
  • T1 : Low to intermediate signal, but areas of hemorrhage may be high.
  • T1 C+ (Gd): shows enhancement (important discriminator from a thrombus) demonstrates uniform heterogeneous enhancement.
  • MRI allows imaging in multiple planes.
  • Provides some functional information such as, flow direction and flow velocity in large vessels.
  • Cannot show calcification.
  • High susceptibility to motion artifact.
  • Dependent on regular electrocardiographic rhythms and cardiac gating.
CT
  • CT can be used to accurately image the heart and surrounding mediastinum.
  • Intracardiac heterogeneously low attenuating mass.
  • The attenuation is usually lower than that of myocardium.
  • Calcification is common
  • CT provides better soft-tissue contrast.
  • There is no real-time true imaging with CT and imaging planes are limited to those allowed by angulation of the gantry.
  • There is no evaluation of small moving structures, such as the cardiac valves.
Angiography
  • Coronary angiography may be helpful to detect vascular supply of the tumor by the coronary arteries.
  • The angiographic findings of cardiac myxoma demonstrate feeding vessels, contrast medium poolings, and clusters of tortuous vessels that correspond to tumor vasculature
  • Angiography can detect the concomitant coronary disease and the unique vascular appearances of cardiac myxoma.
  • Helpful for surgical evaluation.
  • Invasive imaging technique
Chest x-ray
  • Chest x-ray has no particular findings associated with cardiac myxoma.
  • Results can be normal.
  • Low cost
  • May be helpful, if calcifications present.
  • Does not provide a diagnosis.

References

  1. Cardiac Myxoma. Radiopedia.http://radiopaedia.org/articles/cardiac-myxoma Accessed on November 24, 2015
  2. Reeder GS, Khandheria BK, Seward JB, Tajik AJ (1991). "Transesophageal echocardiography and cardiac masses". Mayo Clin. Proc. 66 (11): 1101–9. PMID 1943240.


Template:WikiDoc Sources